Riskpilot← Back to searchSign inGet full accessPIOMED AS
ASActiveOrg 987394870Travbaneveien 3, 4031 StavangerBusiness and other management consultancy activities · NACE 7020Est. 20042 employeeswww.piomed.no
Revenue 2024
NOK 98K
-48% vs 2023
EBITDA margin
-169.2%
+6% vs 2023
Equity ratio
97.9%
Financial strength
Net profit 2024
NOK 382K
+64% vs 2023
| Revenue | NOK 98K | -48% |
| EBITDA | NOK -166K | +6% |
| Net profit | NOK 382K | +64% |
| Total assets | NOK 19,9M | -3% |
| Equity | NOK 19,5M | -5% |
| Employees | 2 | — |
Legal name
PIOMED AS
Org number
987394870
Legal form
Aksjeselskap
NACE code
7020 · Business and other management consultancy activities
Founded
21. oktober 2004
Share capital
NOK 35 332
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Konsulentvirksomhet og investeringer i aksjer/agenturer/verdipapirer/eiendom.
Address
Travbaneveien 3, 4031 Stavanger
Website
www.piomed.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 660 | 1 462 | 1 766 | 1 625 | 1 312 | 951 | 450 | 21 | 43 | 30 | 38 | 557 | 384 | 188 | 188 | 98 |
| Staff expenses | −399 | −344 | −436 | −429 | −6 | −6 | −6 | −4 | −4 | −4 | −34 | −771 | −520 | −324 | −75 | −211 |
| EBITDA | 25 | −18 | −9 | 43 | 71 | 49 | 66 | 0 | 13 | −7 | −52 | −248 | −269 | −385 | −177 | −166 |
| Depreciation & amort. | −9 | −9 | −20 | −66 | −50 | −36 | −29 | −23 | −18 | −14 | −56 | −96 | −26 | −212 | −17 | −0 |
| EBIT | 16 | −27 | −29 | −24 | 21 | 13 | 37 | −23 | −5 | −20 | −108 | −345 | −296 | −597 | −194 | −166 |
| Net financials | 28 | 28 | 21 | 36 | 38 | 185 | 2 068 | 1 080 | 872 | 1 119 | 2 065 | 6 031 | 69 | 14 507 | 427 | 548 |
| Profit before tax | 44 | 1 | −7 | 12 | 59 | 198 | 2 105 | 1 058 | 867 | 1 099 | 1 957 | 5 687 | −227 | 13 910 | 233 | 382 |
| Tax | 12 | 0 | −3 | 2 | 6 | 2 | 13 | 3 | 13 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 32 | 1 | −4 | 10 | 53 | 195 | 2 093 | 1 055 | 854 | 1 099 | 1 957 | 5 687 | −227 | 13 910 | 233 | 382 |
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 456 | 514 | 589 | 727 | 462 | 496 | 2 556 | 3 218 | 4 090 | 6 078 | 6 968 | 12 249 | 9 659 | 22 416 | 20 545 | 19 921 |
| Equity | 178 | 179 | 175 | 185 | 238 | 433 | 2 526 | 3 181 | 4 035 | 6 064 | 6 876 | 11 963 | 8 735 | 21 146 | 20 528 | 19 511 |
| Long-term debt | 0 | 0 | 0 | 161 | 127 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 97 | 0 | 0 |
| Short-term debt | 278 | 336 | 414 | 380 | 97 | 62 | 30 | 37 | 54 | 14 | 92 | 286 | 924 | 1 173 | 17 | 410 |
| Total debt | 278 | 336 | 414 | 541 | 224 | 63 | 30 | 37 | 55 | 15 | 92 | 286 | 924 | 1 270 | 17 | 410 |
EBITDA margin
-169.2%
This company
15.8%
Market median
-1171% vs market
20092024
Equity ratio
97.9%
This company
38.2%
Market median
+156% vs market
20092024
Return on equity
2.0%
This company
18.4%
Market median
-89% vs market
20092024
Net profit margin
390.1%
This company
8.1%
Market median
+4716% vs market
20092024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20092024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2018 | — | — | |
| Chairman | 2018 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PIOMED AS 
Sum Pluss AsBoard members of PIOMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gunn Helen Voll | Board of Directors | 0 companies |
| Roar Voll | Chairman | 0 companies |